Crispr Therapeutics shares owned by National Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by National Asset Management
from 13F filings
Historical chart of National Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by National Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by National Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $479k | 8.9k | 54.01 |
| 2024-03-31 | $763k | 17k | 45.39 |
| 2023-12-31 | $1.0M | 17k | 62.60 |
| 2023-09-30 | $763k | 17k | 45.39 |
| 2023-06-30 | $461k | 8.2k | 56.14 |
| 2023-03-31 | $290k | 6.4k | 45.23 |
| 2022-12-31 | $278k | 6.8k | 40.65 |
| 2022-09-30 | $527k | 8.1k | 65.44 |
| 2022-06-30 | $516k | 8.5k | 60.82 |
| 2022-03-31 | $461k | 7.3k | 62.90 |
| 2021-12-31 | $535k | 7.1k | 75.84 |
| 2021-09-30 | $1.1M | 9.8k | 111.99 |
| 2021-06-30 | $1.0M | 6.4k | 161.94 |
| 2021-03-31 | $605k | 5.0k | 121.98 |
| 2020-12-31 | $643k | 4.2k | 153.13 |
| 2020-09-30 | $378k | 4.5k | 83.70 |
| 2020-06-30 | $323k | 4.4k | 73.63 |
| 2020-03-31 | $201k | 4.7k | 42.56 |
| 2019-12-31 | $287k | 4.7k | 61.01 |
| 2019-06-30 | $362k | 7.7k | 47.14 |